CoChat

Early detection of lung cancer biomarkers through biosensor technology: A review

Roointan, Amir, Ahmad Mir, Tanveer, Ibrahim Wani, Shadil, Mati-ur-Rehman, Hussain, Khalil Khadim, Ahmed, Bilal, Abrahim, Shugufta, Savardashtaki, Amir, Gandomani, Ghazaal, Gandomani, Molood, Chinnappan, Raja, Akhtar, Mahmood H · 2019 · Journal of Pharmaceutical and Biomedical Analysis
Cited by 192

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No Caption available. HighlightsThis review focuses on the early detection of lung cancer biomarkers.Latest biosensing approaches for lung cancer detection studies are addressed.Conventional methods for lung cancer biomarkers detection are also summarized. Abstract Lung cancer is undoubtedly one of the most serious health issues of the 21 st century. It is the second leading cause of cancer‐related deaths in both men and women worldwide, accounting for about 1.5 million deaths annually. Despite advances in the treatment of lung cancer with new pharmaceutical products and technological improvements, morbidity and mortality rates remains a significant challenge for the cancer biologists and oncologists. The vast majority of lung cancer patients present with advanced‐stage of pathological process that ultimately leads to poor prognosis and a five‐year survival rate less than 20%. Early and accurate screening and analysis using cost‐effective means are urgently needed to effectively diagnose the disease, improve the survival rate or to reduce mortality and morbidity associated with lung cancer patients. Thus, the only hope for early recognition of risk factors and timely diagnosis and treatment of lung cancer is biosensors technology. Novel biosensing based diagnostics approaches for predicting metastatic risks are likely to have significant therapeutic and clinical impact in the near future. This article systematically provides a brief overview of various biosensing platforms for identification of lung cancer disease biomarkers, with a specific focus on recent advancements in electrochemical and optical biosensors, analytical performances of different biosensors, challenges and further research opportunities for routine clinical analysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpba.2018.10.017

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Metadata

Authors
Roointan, A., Ahmad Mir, T., Ibrahim Wani, S., Mati-ur-Rehman, Hussain, K. K., Ahmed, B., Abrahim, S., Savardashtaki, A., Gandomani, G., Gandomani, M., Chinnappan, R., & Akhtar, M. H.
Venue
Journal of Pharmaceutical and Biomedical Analysis
Publisher
Elsevier BV
Published
2019-02
Volume
164
Pages
93-103
ISSN
0731-7085 (ISSN-L)
OpenAlex
W2897393632
Cited by
192
References
8
FWCI
5.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early detection of lung cancer biomarkers through biosensor technology: A review. https://app.cochat.ai/papers/10.1016/j.jpba.2018.10.017
The paper
Roointan, A., Ahmad Mir, T., Ibrahim Wani, S., Mati-ur-Rehman, Hussain, K. K., Ahmed, B., Abrahim, S., Savardashtaki, A., Gandomani, G., Gandomani, M., Chinnappan, R., & Akhtar, M. H. (2019). Early detection of lung cancer biomarkers through biosensor technology: A review. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2018.10.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.